Federico is a molecular biologist and bioethicist. For ITINERARE, he researches the trade-offs between costs and benefits for rare diseases in Switzerland. His work aims to describe and determine which factors shape decision-making in the Swiss public when faced with a scarcity of resources for the treatment of patients with rare and debilitating diseases.